The Safety, Tolerability, and Efficacy of Once-Daily Memantine (28 mg): A Multinational, Randomized, Double-Blind, Placebo-Controlled Trial in Patients with Moderate-to-Severe Alzheimer’s Disease Taking Cholinesterase Inhibitors

被引：0
|
作者：
George T. Grossberg
Facundo Manes
Ricardo F. Allegri
Luis Miguel Gutiérrez-Robledo
Sergio Gloger
Lei Xie
X. Daniel Jia
Vojislav Pejović
Michael L. Miller
James L. Perhach
Stephen M. Graham
机构：
[1] Saint Louis University School of Medicine,Department of Neurology and Psychiatry
[2] Instituto de Neurología Cognitiva (INECO),undefined
[3] Instituto de Investigaciones Neurológicas Raúl Carrea (FLENI),undefined
[4] Instituto de Geriatría,undefined
[5] Institutos Nacionales de Salud de México,undefined
[6] PsicoMedica Clinical and Research Group,undefined
[7] Forest Research Institute,undefined
[8] Prescott Medical Communications Group,undefined
来源：
CNS Drugs | 2013年 / 27卷
关键词：
Memantine; Cholinesterase Inhibitor; Semantic Fluency; Verbal Fluency Test; Severe Impairment Battery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：469 / 478
页数：9
相关论文
共 50 条
  • [41] Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial
    Farnia, Vahid
    Gharehbaghi, Haniyeh
    Alikhani, Mostafa
    Almasi, Afshin
    Golshani, Sanobar
    Tatari, Faeze
    Davarinejad, Omran
    Salemi, Safora
    Bahmani, Dena Sadeghi
    Holsboer-Trachsler, Edith
    Brand, Serge
    JOURNAL OF PSYCHIATRIC RESEARCH, 2018, 104 : 137 - 143
  • [42] Efficacy and Safety of Once-Daily Controlled-Release Pregabalin for the Treatment of Patients With Postherpetic Neuralgia A Double-Blind, Enriched Enrollment Randomized Withdrawal, Placebo-Controlled Trial
    Huffman, Cynthia L.
    Goldenberg, James N.
    Weintraub, James
    Sanin, Luis
    Driscoll, Joseph
    Yang, Ruoyong
    Chew, Marci L.
    Scavone, Joseph M.
    CLINICAL JOURNAL OF PAIN, 2017, 33 (07): : 569 - 578
  • [43] A Randomized, Double-Blind, Placebo-Controlled, Phase II Study Assessing Safety, Tolerability, and Efficacy of Bryostatin in the Treatment of Moderately Severe to Severe Alzheimer's Disease
    Farlow, Martin R.
    Thompson, Richard E.
    Wei, Lee-Jen
    Tuchman, Alan J.
    Grenier, Elaine
    Crockford, David
    Wilke, Susanne
    Benison, Jeffrey
    Alkon, Daniel L.
    JOURNAL OF ALZHEIMERS DISEASE, 2019, 67 (02) : 555 - 570
  • [44] Efficacy and Safety of GR1802 in Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial
    Wang, Shangshang
    Zhang, Litao
    Liang, Yunsheng
    Zhang, Shifa
    Wang, Jingyan
    Man, Xiaoyong
    Ji, Chao
    Chen, Rixin
    Xiang, Guang
    Meng, Zudong
    Yang, Chunjun
    Cheng, Hao
    Wang, Qi
    Li, Lin-feng
    Zhang, Siping
    Ding, Yanfeng
    Zhu, Quangang
    Qin, Lanying
    Li, Yumei
    Lu, Qianjin
    Xia, Li
    Cao, Shuanglin
    Yu, Chunshui
    Duan, Xinsuo
    Wu, Liming
    Zhang, Chunlei
    Jiang, Congjun
    Wang, Wei
    Xu, Jinhua
    DERMATOLOGIC THERAPY, 2025, 2025 (01)
  • [45] Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
    Merola, Joseph F.
    Parish, Lawrence Charles
    Guenther, Lyn
    Lynde, Charles
    Lacour, Jean -Philippe
    Staubach, Petra
    Cheng, Sue
    Paris, Maria
    Picard, Hernan
    Deignan, Cynthia
    Jardon, Shauna
    Chen, Mindy
    Papp, Kim A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (03) : 485 - 493
  • [46] The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis:: a randomized, double-blind, placebo-controlled study
    Stjärne, P
    Blomgren, K
    Cayé-Thomasen, P
    Salo, S
    Soderstrom, T
    ACTA OTO-LARYNGOLOGICA, 2006, 126 (06) : 606 - 612
  • [47] Efficacy, Safety, and Subject Satisfaction of PrabotulinumtoxinA for Moderate-to-Severe Crow's Feet: A Phase IV, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
    Lee, Soo-Kyung
    Kim, Myoung Shin
    Kwon, Soon-Hyo
    Chung, Bo Young
    Han, Se Hee
    Kim, Hyoung Jun
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [48] A randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of neramexane in patients with moderate to severe subjective tinnitus
    Suckfuell, Markus
    Althaus, Michael
    Ellers-Lenz, Barbara
    Gebauer, Alexander
    Goertelmeyer, Roman
    Jastreboff, Pawel J.
    Moebius, Hans J.
    Rosenberg, Tanja
    Russ, Hermann
    Wirth, Yvonne
    Krueger, Hagen
    BMC EAR NOSE AND THROAT DISORDERS, 2011, 11
  • [49] Comparing the efficacy and safety of Crocus sativus L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
    Farokhnia, Mehdi
    Sabet, Mehdi Shafiee
    Iranpour, Negar
    Gougol, Amirhossein
    Yekehtaz, Habibeh
    Alimardani, Roozbeh
    Farsad, Farzaneh
    Kamalipour, Maryam
    Akhondzadeh, Shahin
    HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2014, 29 (04) : 351 - 359
  • [50] Efficacy and Safety of Baricitinb in a Phase 3, Randomized, Double-Blind, Placebo-Controlled Study in Pediatric Patients with Moderate-to-Severe Atopic Dermatitis
    Torrelo, A.
    Rewerska, B.
    Paller, Amy
    Prakash, A.
    Zhu, D.
    Pontes, M.
    Wu, Wen-Shuo
    Eichenfield, Lawrence F.
    Boecker, Ulrike
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 99 - 99
12345